CT可检测的预期与非预期免疫相关不良事件
回顾性分析129例接受单药免疫检查点抑制剂治疗并具有基线及随访CT的晚期癌症患者,由两名放射科医生共识阅片。25例(19.4%)发现免疫相关不良事件,其中胸部并发症14/25(56.0%),包括放射性回忆性肺炎、短暂无症状性肺部阴影、过敏性肺炎、弥漫性肺泡损伤、机化性肺炎和类肉瘤样反应;肺外并发症11/25(44.0%),包括结肠炎、胆囊炎、胰腺炎和内脏缺血。
要点
- 接受ICI治疗的患者中约19.4%在CT上出现免疫相关不良事件,胸部最常见(56.0%)。
- 胸部irAES表现多样,包括放射性回忆性肺炎、TAPOs、过敏性肺炎、弥漫性肺泡损伤、机化性肺炎和类肉瘤样反应。
- 肺外irAES包括结肠炎、胆囊炎、胰腺炎和内脏缺血,阅片时需注意这些非胸部表现。
关键影像表现/征象
- 胸部irAES 14/25(56.0%):3例放射性回忆性肺炎、3例短暂无症状性肺部阴影(TAPOs)、3例过敏性肺炎、2例弥漫性肺泡损伤、2例机化性肺炎、1例类肉瘤样反应。
- 肺外irAES 11/25(44.0%):3例结肠炎、4例胆囊炎、2例胰腺炎、2例内脏缺血。
临床应用与阅片要点
- 阅片时需系统评估胸部及肺外表现,警惕irAES的多样影像征象。
- 肺炎为最常见irAES,但国际间质性肺病分类似乎不能涵盖所有药物相关肺毒性,需结合临床-实验室数据综合判断。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: Cancer treatments with immune checkpoint inhibitors (ICI) are associated with a unique set of drug toxicities called immune-related adverse events (irAES). The aim of the present study was to describe the radiological manifestation of irAES detectable by CT.
METHOD: Retrospective analysis of 284 patients treated with ICI for various types of advanced cancer; of them, 129 patients were selected, all having been treated with single-agent ICI, and all with a baseline CT scan and follow-up scans available at our Institute. CT examinations were reviewed by two radiologists involved in the study with a consensus reading. Imaging findings consistent with irAES were reported and correlated with clinical-laboratory data.
RESULTS: Immune-related adverse events were found in 25/129 (19.4 %) patients. No statistically significant differences were found in either the prevalence of irAES or in the time of onset of tumour type. Thoracic complications were detected in 14/25 (56.0 %) patients consisting in: 3 radiation recall pneumonia, 3 Transient Asymptomatic Pulmonary Opacities (TAPOs), 3 hypersensitivity pneumonia, 2 diffuse alveolar damage, 2 organizing pneumonia, 1 sarcoid-like reaction. In the remaining 11/25 (44.0 %), there were extra-pulmonary complications: 3 colitis, 4 cholecystitis, 2 pancreatitis and 2 cases of visceral ischemia.
CONCLUSIONS: Radiologists should be aware of the wide spectrum of irAES as they could affect the outcome. Pneumonia is the most frequent irAES; however, the international classification for interstitial lung disease does not seem to be capable of describing all possible drug-related pulmonary toxicities. Additional findings included TAPOs, radiation recall pneumonia and sarcoid-like reaction.
引用
- Ciccarese F, Piccinino A, Brocchi S, et al. Expected and non-expected immune-related adverse events detectable by CT. Eur J Radiol. 2021. PMID: 33676358. doi:10.1016/j.ejrad.2021.109617
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。